Cover Image

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

Saved in:

Bibliographic Details
Main Authors:	Raphael Reinhard, MD (Author), Christoffer Gebhardt, MD (Author), Nolwenn Maurier, MD (Author), Lionel Larribère, PhD (Author), Azadeh Orouji, MD (Author), Jochen Utikal, MD (Author)
Format:	Book
Published:	Elsevier, 2018-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases
by: Christopher C. Hemond MD, et al.
Published: (2021)

BRAF/MEK inhibitor-induced remission of primary cutaneous myoepithelial carcinoma after local recurrence
by: Jacqueline Guidry, MD, et al.
Published: (2020)

Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
by: Pópulo H, et al.
Published: (2021)

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024)

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase
by: Valerie Glutsch, et al.
Published: (2020)

BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
by: Simeng Zhang, et al.
Published: (2023)

Therapeutic Effectiveness of Immunoradiotherapy on Brain-metastatic BRAF/MEK Inhibitor-resistant Melanoma with Balloon Cell Change
by: Haruka Goto, et al.
Published: (2019)

Epidermotropic metastatic melanoma with perilesional depigmentation in an Indian male
by: Bhavana Doshi, et al.
Published: (2013)

Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation
by: D. Yu. Belousov, et al.
Published: (2018)

Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases
by: Cristina Pellegrini, et al.
Published: (2020)

Epidermotropic marginal zone lymphoma: An uncommon cutaneous B-cell lymphoma responsive to rituximab
by: Cynthia M. Magro, MD, et al.
Published: (2017)

Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma
by: S. K. Zyryanov, et al.
Published: (2024)

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec
by: Jonathan T. Blackmon, et al.
Published: (2017)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023)

Synchronous bilateral axillary sentinel lymph node metastases in a patient with truncal melanoma
by: Shena Kravitz, MD, et al.
Published: (2022)

Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
by: Alice Ramondetta, et al.
Published: (2020)

Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy
by: Blake W. Boudreaux, MD, et al.
Published: (2021)

Locoregional melanoma metastases resistant to PD-1 inhibitor therapy treated with intralesional talimogene laherparepvec
by: Matthew M. Wallace, MD, et al.
Published: (2024)

Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation
by: Kerasia-Maria Plachouri, MD, et al.
Published: (2017)

Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib
by: Marco Caruana, MD, et al.
Published: (2020)

Teledermatology expedites urgent care for a case of acral melanoma with cutaneous in-transit metastases
by: Joseph W. Mocharnuk, BS, et al.
Published: (2021)

Metastasizing Bronchopulmonary Leiomyosarcoma
by: Speros Livieratos MD, et al.
Published: (2015)

MEK inhibitors for the treatment of NRAS mutant melanoma
by: Sarkisian S, et al.
Published: (2018)

Multiple cutaneous melanomas associated with gastric and brain metastases
by: Lara Caroline Grander, et al.
Published: (2016)

Skin proteomic analysis of immune activation associated with regression of melanoma metastases induced by diphencyprone
by: Joseph Han, BS, et al.
Published: (2022)

BRAF Mutation Heterogeneity in Melanoma Lesions
by: Kaori Sakaizawa, et al.
Published: (2020)

Dabrafenib for treatment of BRAF-mutant melanoma
by: Kainthla R, et al.
Published: (2013)

Primary gastric choriocarcinoma with multiple metastases - A case report and literature review of carcinogenesis
by: Yiqin Xiong, MD, PhD, et al.
Published: (2019)

Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation
by: Anna Rodzajewska, et al.
Published: (2023)

Acral lentiginous melanoma with multiple brain metastases in an Indian male
by: Kumar Parimalam, et al.
Published: (2016)

Treponema Pallidum epidermotropism in nodular secondary syphilis
by: Jorge Magdaleno-Tapial, et al.
Published: (2018)

Medulloblastoma in an Adult With Late Extraneural Metastases to the Mediastinum
by: Abhimanyu Ghose MD, et al.
Published: (2014)

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
by: Gulietta M. Pupo, et al.
Published: (2017)

A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination
by: Manrose Singh, et al.
Published: (2024)

A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib
by: Mary Clark, MD, et al.
Published: (2022)

Melanoma with gastric metastases
by: Katherine Wong, et al.
Published: (2016)

Correlation of histopathological patterns in cutaneous melanoma with BRAF mutations Correlação de padrões histopatológicos de melanomas cutâneos com mutações BRAF
by: Juliana Elizabeth Jung, et al.
Published: (2010)

A Case Report of Primary Malignant Melanoma of the Gallbladder with Multiple Metastases
by: Steven H. Adams, et al.
Published: (2023)

First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma
by: Bao D. Dao MD, et al.
Published: (2015)

Benign Metastasizing Leiomyoma Causing Severe Tricuspid Regurgitation and Heart Failure
by: Mohammad Jaber MD, et al.
Published: (2023)